SeQuent Scientific and Viyash Lifesciences Announce Merger

  • calendar27 Sept, 01:52 AM (GMT+5:30)
  • time3 Min
  • share

Summary

SeQuent Scientific, a key player in the global animal health market, announced a merger on September 26 with Viyash Lifesciences Private Limited, an integrated pharmaceutical company.

SeQuent Scientific and Viyash Lifesciences Announce Merger

Key Takeaways from SeQuent Scientific and Viyash Lifesciences Merger:

  • SeQuent Scientific merges with Viyash Lifesciences on September 26.
  • The merger strengthens the R&D and manufacturing capacities of both companies.
  • The new entity will operate in over 150 countries with 16 advanced manufacturing facilities.
  • Viyash shareholders will receive 56 shares of SeQuent for every 100 shares they hold.
  • The entity will have five times more R&D talent and nine times more USFDA-approved manufacturing facilities.

The merger will combine SeQuent's and Viyash's strengths, enhancing their research and development (R&D) capabilities and manufacturing capacities. The new entity will operate in over 150 countries and will have 16 state-of-the-art manufacturing facilities, significantly increasing its market reach.

Under the merger plan, Viyash shareholders will receive shares of SeQuent at a ratio of 56 shares for every 100 shares they hold. The combined company will have 5x more research and development talent and 9x more manufacturing facilities approved by the USFDA. 

Commenting on the proposed merger, Rajaram Narayanan, Managing Director and CEO of SeQuent said,  “We believe that in order to continue to deliver differentiated value to our customers in times to come, it is imperative to scale up our product development and R&D capabilities to capture the market opportunity we are seeing and to build on our leadership in the Animal health market. …Together, we will turbocharge our growth engines including capturing the market opportunity in the overall global pharma markets enabled by Viyash’s capabilities.” 

Commenting on the proposed merger, Haribabu Bodepudi, Chairman and CEO, Viyash, said, “With our combined resources, R&D capabilities, manufacturing capacities, and streamlined supply chain, we are well-positioned to accelerate growth and offer a wider range of high-quality products to our customers.”

About SeQuent Scientific Limited: 

SeQuent Scientific Limited is based in India and works in the global animal health market. The company has seven manufacturing facilities located in India, Spain, Brazil, and Turkey, all approved by major international regulatory agencies like the US FDA and WHO. SeQuent produces active pharmaceutical ingredients (APIs) and animal health products for over 100 countries and employs more than 1,500 people.

About Viyash Lifesciences Limited: 

Viyash Lifesciences is a complete pharmaceutical company that focuses on niche formulations, APIs, and advanced intermediates. It has a research and development team of over 200 scientists and operates 9 USFDA-approved plants, demonstrating its strong capabilities in R&D and manufacturing. Viyash serves customers in more than 150 countries.

Source - NSE

Take your investment to next level

Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more

Indo Count Expands to West Coast with Acquisition of Modern Home Textiles Inc., USA

Indo Count Expands to West Coast with Acquisition of Modern Home Texti...

Through its U.S. subsidiary, Indo Count Global, Inc. (ICG), this acquisition brings a manufacturing facility in Phoenix, Arizona, with an annual production capa...

Vascon Engineers Receives LOA from MMRCL

Vascon Engineers Receives LOA from MMRCL

Amounting to Rs. 57,22,65,512.75 (excluding GST), the acceptance is for the construction of a commercial building at Kalbadevi (K2) on CS Nos. 663, 664, 665, 1/...

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

This agreement will provide power over 25 years at a tariff rate of ₹2.59 per kilowatt-hour (KWh).

Featured News

Ola Electric Launches Network Partner Program to Boost EV Adoption

Ola Electric Launches Network Partner Program to Boost EV Adoption

To accelerate the adoption of electric vehicles (EVs) across India, Ola Electric has introduced its 'Network Partner Program,' designed to expand its sales and ...

Adani Total Gas Up 8% as Co Secures Largest Global Financing

Adani Total Gas Up 8% as Co Secures Largest Global Financing

The initial funding of $375 million, arranged with overseas lenders, comprises $315 million in commitments and the ability to raise more funds. Five internation...

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Deal with Global Network Partners

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Dea...

As per a stock exchange filing, VIL has renewed its long-term partnerships with Nokia and Ericsson while welcoming Samsung as a new partner. These contracts wil...

Other News Categories

Next News

Purvah Green Power Forms Wholly Owned Subsidiary to Explore Renewable Energy Opportunities

  • calendar27 Sept, 02:19 AM (GMT+5:30)
  • time2 Min
  • share

Summary

Purvah Green Power Private Limited, a subsidiary of the RP- Sanjiv Goenka Group, announced on Thursday, September 26, that it has incorporated a new wholly-owned subsidiary named KUS Renewable Private Limited (KRPL). KRPL, operating in the renewable power sector, was formed to explore opportunities within this growing industry.

Purvah Green Power Forms Wholly Owned Subsidiary to Explore Renewable Energy Opportunities

Key Takeaways from the Announcement

  • Purvah Green Power Private Limited established a wholly-owned subsidiary named KUS Renewable Private Limited (KRPL) on September 26, 2024.
  • KRPL will explore opportunities in the renewable power sector.
  • KRPL is fully owned by Purvah Green Power, with 100% of its shareholding held by the parent company.

As per the stock exchange filing, the new subsidiary, KRPL, is fully owned by Purvah Green Power, meaning 100% of its shareholding is held by Purvah. The paid-up capital of KRPL is ₹1,00,000, and no governmental or regulatory approvals were required for its establishment. Since KRPL is a newly formed entity, the question of acquisition and its completion does not arise.

The creation of KRPL fits with the strategic priorities of Purvah Green Power to support its pursuit of renewable energy opportunities in various of its business lines and to advance the company's overall strategies for all things related to renewables.

About CESC Limited

CESC Ltd., a company in the RP-Sanjiv Goenka Group, was established as the 1st private utility in the country to be involved in power generation, transmission, and distribution, and continues to operate generating electricity for distribution to key markets in West Bengal (Kolkata, Hooghly, Howrah, North and South 24 Parganas)—approximately 3.4 million customers for residential, industrial, and commercial markets. The company is responsible for the execution and management of power generation facilities through subsidiaries in other regions within India while also being responsible for distribution operations in those regions.

Source - NSE

Take your investment to next level

Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more

Indo Count Expands to West Coast with Acquisition of Modern Home Textiles Inc., USA

Indo Count Expands to West Coast with Acquisition of Modern Home Texti...

Through its U.S. subsidiary, Indo Count Global, Inc. (ICG), this acquisition brings a manufacturing facility in Phoenix, Arizona, with an annual production capa...

Vascon Engineers Receives LOA from MMRCL

Vascon Engineers Receives LOA from MMRCL

Amounting to Rs. 57,22,65,512.75 (excluding GST), the acceptance is for the construction of a commercial building at Kalbadevi (K2) on CS Nos. 663, 664, 665, 1/...

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

This agreement will provide power over 25 years at a tariff rate of ₹2.59 per kilowatt-hour (KWh).

Featured News

Ola Electric Launches Network Partner Program to Boost EV Adoption

Ola Electric Launches Network Partner Program to Boost EV Adoption

To accelerate the adoption of electric vehicles (EVs) across India, Ola Electric has introduced its 'Network Partner Program,' designed to expand its sales and ...

Adani Total Gas Up 8% as Co Secures Largest Global Financing

Adani Total Gas Up 8% as Co Secures Largest Global Financing

The initial funding of $375 million, arranged with overseas lenders, comprises $315 million in commitments and the ability to raise more funds. Five internation...

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Deal with Global Network Partners

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Dea...

As per a stock exchange filing, VIL has renewed its long-term partnerships with Nokia and Ericsson while welcoming Samsung as a new partner. These contracts wil...

Other News Categories

Next News

Ganesha Ecosphere Allotted 4,55,000 Equity Shares by Race Eco Chain Limited

  • calendar27 Sept, 02:08 AM (GMT+5:30)
  • time2 Min
  • share

Summary

Ganesha Ecosphere Limited (GESL) has announced on Thursday, September 26, that it has been allotted equity shares from Race Eco Chain Limited on a preferential basis. This acquisition aligns with GESL's strategy to enhance its raw material supply chain, specifically in plastic waste management.

Ganesha Ecosphere Allotted 4,55,000 Equity Shares by Race Eco Chain Limited

Key Takeaways from the Announcement 

  • Ganesha Ecosphere Limited has received 455,000 equity shares from Race Eco Chain Limited.
  • This acquisition is part of GESL’s strategy to enhance its raw material supply chain, particularly focusing on plastic waste management.
  • After this allotment, GESL holds a 2.64% shareholding in Race Eco Chain Limited.

Ganesha Ecosphere Limited (GESL) has announced the allotment of 455,000 equity shares of ₹10 each from Race Eco Chain Limited on a preferential basis, as disclosed in a communication sent to the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) on September 26, 2024. This acquisition aligns with GESL's strategy to enhance its raw material supply chain, specifically in plastic waste management.

Gesl received the shares for an issue price of ₹352 per equity share valued at ₹16.01 crore. After the transactions, GESL owns a 2.64% shareholding interest in RACE. As this acquisition does not breach any existing regulations, no external approvals are required. The agreement transpired per arm's length, nor was there any non-arms length associated party transactions.

Race Eco Chain Limited, incorporated on November 22, 1999, operates in the plastic waste management industry and is listed on both the BSE and NSE. As per its audited financial statements for the year ending March 31, 2024, RACE reported revenue from operations of ₹338.50 crore and a net worth of ₹22.22 crore. 

About Ganesha Ecosphere Limited

Ganesha Ecosphere Ltd. is a leading entity of PET waste recycling in India, with its focus on manufacturing Recycled Polyester Staple Fibre (RPSF), spun and dyed texturized yarns. Ganesha Eco was founded as Ganesh Polytex Ltd in 1987 and adopted its name to Ganesha Ecosphere Ltd in October, 2011.

Source - NSE

Take your investment to next level

Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more

Indo Count Expands to West Coast with Acquisition of Modern Home Textiles Inc., USA

Indo Count Expands to West Coast with Acquisition of Modern Home Texti...

Through its U.S. subsidiary, Indo Count Global, Inc. (ICG), this acquisition brings a manufacturing facility in Phoenix, Arizona, with an annual production capa...

Vascon Engineers Receives LOA from MMRCL

Vascon Engineers Receives LOA from MMRCL

Amounting to Rs. 57,22,65,512.75 (excluding GST), the acceptance is for the construction of a commercial building at Kalbadevi (K2) on CS Nos. 663, 664, 665, 1/...

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

This agreement will provide power over 25 years at a tariff rate of ₹2.59 per kilowatt-hour (KWh).

Featured News

Ola Electric Launches Network Partner Program to Boost EV Adoption

Ola Electric Launches Network Partner Program to Boost EV Adoption

To accelerate the adoption of electric vehicles (EVs) across India, Ola Electric has introduced its 'Network Partner Program,' designed to expand its sales and ...

Adani Total Gas Up 8% as Co Secures Largest Global Financing

Adani Total Gas Up 8% as Co Secures Largest Global Financing

The initial funding of $375 million, arranged with overseas lenders, comprises $315 million in commitments and the ability to raise more funds. Five internation...

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Deal with Global Network Partners

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Dea...

As per a stock exchange filing, VIL has renewed its long-term partnerships with Nokia and Ericsson while welcoming Samsung as a new partner. These contracts wil...

Other News Categories

Next News

Zydus, CDRI to Develop New Osteoporosis Treatment for CKD Patients

  • calendar27 Sept, 01:45 AM (GMT+5:30)
  • time3 Min
  • share

Summary

Zydus Lifesciences and the Central Drug Research Institute (CDRI), on September 27, announced plans to develop safe and effective treatments for osteoporosis in patients with chronic kidney disease (CKD). The collaboration will focus on creating small-molecule inhibitors of Sclerostin that can be taken orally.

Zydus, CDRI to Develop New Osteoporosis Treatment for CKD Patients

Key Takeaways from Zydus and CDRI Development of New Osteoporosis Treatment:

  • Zydus Lifesciences and Central Drug Research Institute (CDRI) collaborate to develop osteoporosis treatments for CKD patients.
  • Existing osteoporosis drugs are often unsuitable for CKD patients due to kidney risks.
  • High levels of Sclerostin are linked to bone metabolism issues in advanced CKD and osteoporosis.
  • Zydus will manage drug development for India and other markets.

CKD affects over 10% of people worldwide and can lead to serious health issues, including bone loss and fractures, especially in older adults.

Current osteoporosis medications are often not suitable for CKD patients due to potential harm to their kidneys. This has created a need for new therapies that can help these patients without worsening their condition.

Research shows that a protein called Sclerostin is linked to bone metabolism issues in CKD patients. Studies indicate that Sclerostin levels are high in those with advanced CKD and osteoporosis. 

On September 17, 2024, the two organizations signed a research agreement at Zydus Research Centre in Ahmedabad. The CDRI team, led by Dr Naibedya Chattopadhyay, will work on identifying compounds that can inhibit Sclerostin signalling, while Zydus will handle drug development for India and other markets.

The partnership aims to create innovative therapies that can improve the quality of life for those affected by CKD and osteoporosis in India.

About Zydus Lifesciences Limited:

Zydus Lifesciences Limited is a global healthcare company focused on helping people live healthier and more fulfilling lives. They discover, develop, manufacture, and market a variety of healthcare therapies, with a strong emphasis on cancer treatments that include cytotoxic, supportive, and targeted drugs. The company employs over 27,000 people worldwide, including 1,400 scientists in research and development. Their mission is to create innovative healthcare solutions that make a difference in people's lives and to achieve transformative discoveries.

About CSIR-Central Drug Research Institute (CSIR-CDRI):  

The CSIR-Central Drug Research Institute (CSIR-CDRI) is a leading drug research institute in India, established on February 17, 1951, by Prime Minister Jawaharlal Nehru. Its goal is to enhance drug research and development in the country. The institute has achieved significant milestones in creating new drugs and technologies for affordable healthcare, generating knowledge, and training future leaders in the healthcare sector.

Today, CSIR-CDRI serves as a model for modern drug research in India, housing everything needed for drug development under one roof—from synthesis and screening to clinical studies. It has discovered and developed 12 new drugs, including Arteether, BESEB, and Centchroman, which are currently available on the market. The institute has also transferred over 130 homegrown technologies to pharmaceutical companies, contributing greatly to the growth of the Indian pharmaceutical industry.

Source - NSE

Take your investment to next level

Open a FREE* Demat and Trading account to invest in Stocks, Mutual Funds, IPOs and more

Indo Count Expands to West Coast with Acquisition of Modern Home Textiles Inc., USA

Indo Count Expands to West Coast with Acquisition of Modern Home Texti...

Through its U.S. subsidiary, Indo Count Global, Inc. (ICG), this acquisition brings a manufacturing facility in Phoenix, Arizona, with an annual production capa...

Vascon Engineers Receives LOA from MMRCL

Vascon Engineers Receives LOA from MMRCL

Amounting to Rs. 57,22,65,512.75 (excluding GST), the acceptance is for the construction of a commercial building at Kalbadevi (K2) on CS Nos. 663, 664, 665, 1/...

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

JSW Energy Signs 700 MW PPA with NTPC for Solar Capacity

This agreement will provide power over 25 years at a tariff rate of ₹2.59 per kilowatt-hour (KWh).

Featured News

Ola Electric Launches Network Partner Program to Boost EV Adoption

Ola Electric Launches Network Partner Program to Boost EV Adoption

To accelerate the adoption of electric vehicles (EVs) across India, Ola Electric has introduced its 'Network Partner Program,' designed to expand its sales and ...

Adani Total Gas Up 8% as Co Secures Largest Global Financing

Adani Total Gas Up 8% as Co Secures Largest Global Financing

The initial funding of $375 million, arranged with overseas lenders, comprises $315 million in commitments and the ability to raise more funds. Five internation...

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Deal with Global Network Partners

Vodafone Idea Shares Surge by 7% Post Announcing Mega $3.6 Billion Dea...

As per a stock exchange filing, VIL has renewed its long-term partnerships with Nokia and Ericsson while welcoming Samsung as a new partner. These contracts wil...

Other News Categories